IL-15 trans-presentation promotes human NK cell development and differentiation in vivo. - Wikidata - awgldk - TriplyDB

IL-15 trans-presentation promotes human NK cell development and differentiation in vivo.

IL-15 trans-presentation promotes human NK cell development and differentiation in vivo.

http://www.wikidata.org/entity/Q37061837

about

IL-15 triggers an antiapoptotic pathway in human intraepithelial lymphocytes that is a potential new target in celiac disease-associated inflammation and lymphomagenesis Translating Treg Therapy in Humanized Mice Effector Functions of Natural Killer Cell Subsets in the Control of Hematological Malignancies Newtonian cell interactions shape natural killer cell education NK Cell-Mediated Antibody-Dependent Cellular Cytotoxicity in Cancer Immunotherapy Development of humanized mouse models to study human malaria parasite infection Natural killer cells generated from cord blood hematopoietic progenitor cells efficiently target bone marrow-residing human leukemia cells in NOD/SCID/IL2Rg(null) mice In vivo administration of a JAK3 inhibitor during acute SIV infection leads to significant increases in viral load during chronic infection Human NK cell development requires CD56-mediated motility and formation of the developmental synapse.CD133, Selectively Targeting the Root of Cancer Genetic Causes of Human NK Cell Deficiency and Their Effect on NK Cell Subsets Dysregulation of Chemokine/Chemokine Receptor Axes and NK Cell Tissue Localization during Diseases Identification of a polyI:C-inducible membrane protein that participates in dendritic cell-mediated natural killer cell activation A novel mouse model for stable engraftment of a human immune system and human hepatocytes Generation of human antigen-specific monoclonal IgM antibodies using vaccinated "human immune system" mice TOX2 regulates human natural killer cell development by controlling T-BET expression Development of functional human NK cells in an immunodeficient mouse model with the ability to provide protection against tumor challenge.Human natural killer cell development in secondary lymphoid tissues Current advances in humanized mouse models.Development and function of human innate immune cells in a humanized mouse model Human monocytes have increased IFN-γ-mediated IL-15 production with age alongside altered IFN-γ receptor signaling.In vivo IFN-γ secretion by NK cells in response to Salmonella typhimurium requires NLRC4 inflammasomes.Impact of Mixed Xenogeneic Porcine Hematopoietic Chimerism on Human NK Cell Recognition in a Humanized Mouse Model IL-7 and IL-15 independently program the differentiation of intestinal CD3-NKp46+ cell subsets from Id2-dependent precursors.Cytokines as Adjuvants for Vaccine and Cellular Therapies for Cancer.Transcriptome analysis reveals similarities between human blood CD3- CD56bright cells and mouse CD127+ innate lymphoid cells.Gliadin-mediated proliferation and innate immune activation in celiac disease are due to alterations in vesicular trafficking Engineering humanized mice for improved hematopoietic reconstitution.Humanized mouse models to study human diseases Human hemato-lymphoid system mice: current use and future potential for medicine.IL-18, but not IL-15, contributes to the IL-12-dependent induction of NK-cell effector functions by Leishmania infantum in vivo.Innate immune natural killer cells and their role in HIV and SIV infection.Metronomic cyclophosphamide schedule-dependence of innate immune cell recruitment and tumor regression in an implanted glioma model Highly potent anti-CD20-RLI immunocytokine targeting established human B lymphoma in SCID mouse.IL-15 participates in the respiratory innate immune response to influenza virus infection CD57 defines a functionally distinct population of mature NK cells in the human CD56dimCD16+ NK-cell subset.Human NK cells of mice with reconstituted human immune system components require preactivation to acquire functional competence.Co-administration of avian influenza virus H5 plasmid DNA with chicken IL-15 and IL-18 enhanced chickens immune responses.Current humanized mouse models for studying human immunology and HIV-1 immuno-pathogenesis.Rapid expansion and long-term persistence of elevated NK cell numbers in humans infected with hantavirus.

P2860

Q24604346-23811CCE-FA97-419D-8AC9-95992150B95B Q26772335-F4425CBD-340C-446B-8D0A-1CD7035CC396 Q26776538-843EBB7A-C3C0-4A3E-AF91-FF428840041F Q26797240-60039AB1-7C5E-4049-BBB6-F05BF2DD17B4 Q26797345-2279A040-0C3C-419F-940E-2811C64E50BB Q26851983-7F45AA55-1180-4B52-B11B-6BF6A1B6E111 Q27318729-91B09A71-DC5A-4160-94CA-524A4EB597D7 Q27330386-386325B7-0405-44A1-8A06-D5F952269A20 Q27335804-CA14F034-43E3-48BF-A49C-29C7AB3B005E Q28066353-E54D5FE7-4527-4748-8139-E3C607C29F70 Q28067993-BBB59D15-9E89-4C7A-9C87-8300E0561787 Q28079140-921A97F5-5BAF-4411-A54D-007625505CF6 Q28508164-6D5925EE-5176-4BD5-9319-E02BB9330B4F Q28544456-E8F9E6EB-5E93-4B37-99C8-6E2D930F8B7A Q28749033-E4CB8B64-8A5B-4620-86BD-864F454C5074 Q28854590-0B3BD1CA-CCB7-40B7-9724-6BF58D87047A Q33520247-85A9E4FA-83B9-41BB-A568-96260086EF72 Q33567199-13CD227D-05BC-487D-94F7-B33CEE40E5B8 Q33577361-33135CB3-F0EB-4F85-9F3B-3D1DE79E0F44 Q33596915-06BACB78-49E0-4838-A54A-A7D405645E48 Q33601367-F2C83F72-795D-44F7-B5D7-CD1F1F1AF568 Q33610279-4AFE081B-BBEE-49FB-9DC6-FAAFF3F83C96 Q33629253-A6422543-8515-4D0C-8455-E8FBB028594B Q33656197-574479B8-E388-4715-B04D-3A18A022B46E Q33680566-5770A2E6-F5BA-4A6C-8A24-FC39B69FF107 Q33799561-C4E9568F-1B2A-4187-B1AF-1C6F725CF27D Q33833760-F2517F57-259E-4BFF-A916-84291C593A98 Q33844310-E4059BF2-A621-4D51-B15D-FFD22AA5B7C4 Q33941638-99602B83-8ABB-4074-8E3E-2E469ECE571F Q33995307-709CA4D7-5B02-400B-BE46-55097E59A4B4 Q34017578-32372C86-7FFF-4812-A528-708018A2C2F7 Q34070433-CD58A946-C867-48CE-897C-499467AF3433 Q34173568-9FED59F2-C967-4413-A154-5BA017ED6D85 Q34223872-CD9FBF80-C534-4232-98F2-D1395227B7F0 Q34280059-55212849-717D-4A0A-923A-723739B992F7 Q34310907-88CB0879-939D-4FB4-A4F0-8D49D15AF0BC Q34360327-9B3C9715-FC3C-42A9-96D4-09AF70B74A3E Q34367306-9888E790-19E7-4E82-9C6E-65A9D3DA6EA8 Q34474320-1D788BE1-9A72-4374-BD26-EC2776AE6DDE Q34501427-559B11F2-D029-4157-B3E4-0D0D119D0010

P2860

IL-15 trans-presentation promotes human NK cell development and differentiation in vivo.

http://www.wikidata.org/entity/Q37061837

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 22 December 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

IL-15 trans-presentation promotes human NK cell development and differentiation in vivo.

@en

IL-15 trans-presentation promotes human NK cell development and differentiation in vivo.

@nl

type

label

IL-15 trans-presentation promotes human NK cell development and differentiation in vivo.

@en

IL-15 trans-presentation promotes human NK cell development and differentiation in vivo.

@nl

prefLabel

IL-15 trans-presentation promotes human NK cell development and differentiation in vivo.

@en

IL-15 trans-presentation promotes human NK cell development and differentiation in vivo.

@nl

P1433

Q37061837-0429726B-8799-434A-A74D-6AEFFC7405C5

P1476

Q37061837-216431C0-B09E-4E00-AC76-86D338A15D4F

P2093

Q37061837-1418656D-6581-42D0-BB2A-853D44E0D2B1

Q37061837-1AE8744A-5D4E-42C0-9D52-31C94481D081

Q37061837-205DEBD3-A616-4F25-8A48-258271CB9E6C

Q37061837-2885F60A-7C63-467A-A9BD-2254ECB647E0

Q37061837-377B5704-8C0B-44E8-9521-061E8F1D5B12

Q37061837-4C7EE46F-D1B2-4E7D-94A7-F8C41AEB0C59

Q37061837-5CB9BC96-8AD9-4FD0-9BF8-4AE1A10E860F

Q37061837-74CCC8D2-07F2-452B-933D-3594F1DCC2CA

Q37061837-856F0F25-CBDF-4439-B84D-F49444DDEA9C

Q37061837-C6B1CC8A-D159-4A02-BB6B-81F05CECE1BB

P2860

Q37061837-098974E4-D608-47AB-B2BA-592A2A2D1ADF

Q37061837-12F8D590-F54B-4BD8-B862-2BEC84F88CB4

Q37061837-19B543D1-6160-47E2-96BD-DD680A233180

Q37061837-1CEC1007-6AC7-490A-B56E-543F7E617A41

Q37061837-20098E28-73D3-453D-BE64-66BAB7449DEC

Q37061837-2571B029-BE4A-47F0-BE72-A7695732BEE2

Q37061837-3EA649AC-5FBD-4B5C-9131-5966D714A3A6

Q37061837-4C46992E-7693-4AE5-A5EC-59BB692F604A

Q37061837-4EB784EF-D109-4B52-A386-0AB68F9F7CF9

Q37061837-569550CC-3060-40A5-8FAC-5CE94D413450

P304

Q37061837-95017EBD-1272-4AF6-9A12-1E9C0BCD941E

P31

Q37061837-3E2AEE85-8598-4AEC-B833-2685EBD79456

P356

Q37061837-DB654A97-F90A-4C4A-8AA7-7D8FF2143089

P407

Q37061837-AF90DD6A-737E-4DE5-931D-C0D7E2E85A46

P433

Q37061837-75C334C6-1B2B-4312-9EE6-450504D41DC2

P478

Q37061837-67D49B15-A025-4183-B417-CE7FA958AEEF

P577

Q37061837-1F390729-0FCB-4FC0-9646-1968649063A9

P5875

Q37061837-796AD2BE-0EBC-409C-88F9-3C14587ABD62

P698

Q37061837-DC565891-99E5-4CCE-858E-D15213302FE8

P932

Q37061837-D788A4C1-5867-4A32-96AD-69C1E1002F78

P356

P1433

Journal of Experimental Medicine

P1476

IL-15 trans-presentation promotes human NK cell development and differentiation in vivo.

@en

P2093

Ariane Plet

http://www.w3.org/2001/XMLSchema#string

Barbara Jaron

http://www.w3.org/2001/XMLSchema#string

Erwan Corcuff

http://www.w3.org/2001/XMLSchema#string

Erwan Mortier

http://www.w3.org/2001/XMLSchema#string

Hergen Spits

http://www.w3.org/2001/XMLSchema#string

James P Di Santo

http://www.w3.org/2001/XMLSchema#string

Kees Weijer

http://www.w3.org/2001/XMLSchema#string

Nicholas D Huntington

http://www.w3.org/2001/XMLSchema#string

Nicolas Legrand

http://www.w3.org/2001/XMLSchema#string

Nuno L Alves

http://www.w3.org/2001/XMLSchema#string

P2860

Soluble interleukin-15 receptor alpha (IL-15R alpha)-sushi as a selective and potent agonist of IL-15 action through IL-15R beta/gamma. Hyperagonist IL-15 x IL-15R alpha fusion proteins

Homozygous human TAP peptide transporter mutation in HLA class I deficiency

Molecular defects in human severe combined immunodeficiency and approaches to immune reconstitution

Combined IL-15/IL-15Ralpha immunotherapy maximizes IL-15 activity in vivo.

Interleukin 15: biology and relevance to human disease.

Interleukin 15-mediated survival of natural killer cells is determined by interactions among Bim, Noxa and Mcl-1.

Converting IL-15 to a superagonist by binding to soluble IL-15R{alpha}

A subpopulation of human peripheral blood NK cells that lacks inhibitory receptors for self-MHC is developmentally immature

The impact of variation at the KIR gene cluster on human disease.

Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor.

P304

25-34

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1084/JEM.20082013

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

206

http://www.w3.org/2001/XMLSchema#string

P577

2008-12-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23685484

http://www.w3.org/2001/XMLSchema#string

P698

19103877

http://www.w3.org/2001/XMLSchema#string

P932

2626663

http://www.w3.org/2001/XMLSchema#string